Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 1 |
2012 | 1 |
2018 | 1 |
2021 | 1 |
2022 | 2 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Chromatographic capture of cells to achieve single stage clarification in recombinant protein purification.
Biotechnol Prog. 2022 Mar;38(2):e3227. doi: 10.1002/btpr.3227. Epub 2021 Dec 8.
Biotechnol Prog. 2022.
PMID: 34854259
Free PMC article.
An open-label, dose-ranging study of Rolontis, a novel long-acting myeloid growth factor, in breast cancer.
Vacirca JL, Chan A, Mezei K, Adoo CS, Pápai Z, McGregor K, Okera M, Horváth Z, Landherr L, Hanslik J, Hager SJ, Ibrahim EN, Rostom M, Bhat G, Choi MR, Reddy G, Tedesco KL, Agajanian R, Láng I, Schwartzberg LS.
Vacirca JL, et al. Among authors: hager sj.
Cancer Med. 2018 May;7(5):1660-1669. doi: 10.1002/cam4.1388. Epub 2018 Mar 23.
Cancer Med. 2018.
PMID: 29573207
Free PMC article.
Clinical Trial.
Item in Clipboard
Phase 2 study of add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: final results.
Yacoub A, Borate U, Rampal RK, Ali H, Wang ES, Gerds AT, Hobbs G, Kremyanskaya M, Winton E, O'Connell C, Goel S, Oh ST, Schiller G, McCloskey J, Palmer J, Holmes H, Hager S, Assad A, Erickson-Viitanen S, Zhou F, Daver N.
Yacoub A, et al. Among authors: hager s.
Blood Adv. 2024 Mar 26;8(6):1515-1528. doi: 10.1182/bloodadvances.2023011620.
Blood Adv. 2024.
PMID: 38290135
Free PMC article.
Clinical Trial.
Item in Clipboard
A Rare Presentation of a Non-Asian Female With Metastatic Non-small-cell Lung Cancer Harboring EGFR L747P Mutation With Clinical Response to Multi-targeted Epigenetic and EGFR Inhibition.
Messeha SS, Nezami MA, Hager S, Soliman KFA.
Messeha SS, et al. Among authors: hager s.
Anticancer Res. 2022 Jan;42(1):441-447. doi: 10.21873/anticanres.15502.
Anticancer Res. 2022.
PMID: 34969754
Free PMC article.
Item in Clipboard
Carboplatin plus gemcitabine repeating doublet therapy in recurrent breast cancer.
Nagourney RA, Flam M, Link J, Hager S, Blitzer J, Lyons W, Sommers BL, Evans S.
Nagourney RA, et al. Among authors: hager s.
Clin Breast Cancer. 2008 Oct;8(5):432-5. doi: 10.3816/CBC.2008.n.052.
Clin Breast Cancer. 2008.
PMID: 18952557
Clinical Trial.
Item in Clipboard
Phase II study of gemcitabine and bevacizumab as first-line treatment in taxane-pretreated, HER2-negative, locally recurrent or metastatic breast cancer.
Borson R, Harker G, Reeves J, Beck T, Hager S, Horvath W, Jones M, Tillinghast G, Arrowsmith E, Harrer G, Kudrik FJ, Malamud SC, Bromund J, Zeigler H, Tai DF, Kornberg LJ, Obasaju C, Orlando M, Yardley DA.
Borson R, et al. Among authors: hager s.
Clin Breast Cancer. 2012 Oct;12(5):322-30. doi: 10.1016/j.clbc.2012.07.004.
Clin Breast Cancer. 2012.
PMID: 23040000
Clinical Trial.
Item in Clipboard
Cite
Cite